FDA Approves Opdivo for Post-Surgical Stage 2B or 2C Melanoma
The FDA approved Opdivo for the treatment of patients aged 12 years and older with stage 2B or 2C melanoma that has been surgically removed
Source: curetoday.com
Stay updated with breaking news from Melanoma Program Director. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The FDA approved Opdivo for the treatment of patients aged 12 years and older with stage 2B or 2C melanoma that has been surgically removed
Press release content from Business Wire. The AP news staff was not involved in its creation.